Literature DB >> 10464140

Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

C Rose1, R F Butterworth, J Zayed, L Normandin, K Todd, A Michalak, L Spahr, P M Huet, G Pomier-Layrargues.   

Abstract

BACKGROUND & AIMS: Manganese (Mn) deposition could be responsible for the T(1)-weighted magnetic resonance signal hyperintensities observed in cirrhotic patients. These experiments were designed to assess the regional specificity of the Mn increases as well as their relationship to portal-systemic shunting or hepatobiliary dysfunction.
METHODS: Mn concentrations were measured in (1) brain samples from basal ganglia structures (pallidum, putamen, caudate nucleus) and cerebral cortical structures (frontal, occipital cortex) obtained at autopsy from 12 cirrhotic patients who died in hepatic coma and from 12 matched controls; and from (2) brain samples (caudate/putamen, globus pallidus, frontal cortex) from groups (n = 8) of rats either with end-to-side portacaval anastomosis, with biliary cirrhosis, or with fulminant hepatic failure as well as from sham-operated and normal rats.
RESULTS: Mn content was significantly increased in frontal cortex (by 38%), occipital cortex (by 55%), pallidum (by 186%), putamen (by 66%), and caudate (by 54%) of cirrhotic patients compared with controls. Brain Mn content did not correlate with patient age, etiology of cirrhosis, or history of chronic hepatic encephalopathy. In cirrhotic and portacaval-shunted rats, Mn content was increased in pallidum (by 27% and 57%, respectively) and in caudate/putamen (by 57% and 67%, respectively) compared with control groups. Mn concentration in pallidum was significantly higher in portacaval-shunted rats than in cirrhotic rats. No significant changes in brain Mn concentrations were observed in rats with acute liver failure.
CONCLUSIONS: These findings suggest that brain Mn deposition results both from portal-systemic shunting and from liver dysfunction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464140     DOI: 10.1016/s0016-5085(99)70457-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  69 in total

Review 1.  Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

2.  Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis.

Authors:  A Rovira; E Grivé; S Pedraza; A Rovira; J Alonso
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

Review 3.  Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy.

Authors:  Laurent Spahr; Pierre R Burkhard; Hannelore Grötzsch; Antoine Hadengue
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

4.  Brain magnetic resonance imaging findings in young patients with hepatosplenic schistosomiasis mansoni without overt symptoms.

Authors:  Adonis Manzella; Paulo Borba-Filho; Carlos T Brandt; Keyla Oliveira
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

Review 5.  Fatigue in primary biliary cirrhosis.

Authors:  Ghulam Abbas; Roberta A Jorgensen; Keith D Lindor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-11       Impact factor: 46.802

6.  Basal ganglia MR relaxometry in obsessive-compulsive disorder: T2 depends upon age of symptom onset.

Authors:  Stephen Correia; Emily Hubbard; Jason Hassenstab; Agustin Yip; Josef Vymazal; Vit Herynek; Jay Giedd; Dennis L Murphy; Benjamin D Greenberg
Journal:  Brain Imaging Behav       Date:  2009-12-12       Impact factor: 3.978

7.  Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study.

Authors:  Vijay P B Grover; Mary M E Crossey; Julie A Fitzpatrick; Brian K Saxby; Roberta Shaw; Adam D Waldman; Marsha Y Morgan; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2015-08-08       Impact factor: 3.584

Review 8.  Functional imaging of the brain in patients with liver cirrhosis.

Authors:  Karin Weissenborn; Martin Bokemeyer; Björn Ahl; Daniela Fischer-Wasels; Kathrin Giewekemeyer; Jörg van den Hoff; Herbert Köstler; Georg Berding
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 9.  Hepatic encephalopathy: a dynamic or static condition.

Authors:  Charmaine A Stewart; Jane Cerhan
Journal:  Metab Brain Dis       Date:  2005-09       Impact factor: 3.584

10.  Acquired hepatocerebral degeneration: A case report.

Authors:  Clarice Listik; Gislaine Cristina Lopes Machado-Porto; Maira Okada de Oliveira; Fábio Henrique de Gobbi Porto
Journal:  Dement Neuropsychol       Date:  2012 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.